financetom
Business
financetom
/
Business
/
Alkami Technology Insider Sold Shares Worth $2,230,131, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alkami Technology Insider Sold Shares Worth $2,230,131, According to a Recent SEC Filing
Feb 27, 2025 12:53 AM

03:31 AM EST, 02/27/2025 (MT Newswires) -- Alex Shootman, Director, Chief Executive Officer, on February 21, 2025, sold 75,000 shares in Alkami Technology ( ALKT ) for $2,230,131. Following the Form 4 filing with the SEC, Shootman has control over a total of 1,066,893 common shares of the company, with 1,066,893 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1529274/000152927425000018/xslF345X05/wk-form4_1740617790.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Franklin Electric Names Joe Ruzynski CEO
Franklin Electric Names Joe Ruzynski CEO
May 14, 2024
08:38 AM EDT, 05/14/2024 (MT Newswires) -- Franklin Electric ( FELE ) said Tuesday it named Joe Ruzynski chief executive officer and a member of its board, effective July 1. Ruzynski, 49, succeeds Gregg Sengstack, chief executive since 2014 and chair since 2015, who will continue as executive chair of the water and energy technology firm's board. Ruzynski previously served...
FMC Partners With Optibrium to Accelerate Pipeline
FMC Partners With Optibrium to Accelerate Pipeline
May 14, 2024
08:35 AM EDT, 05/14/2024 (MT Newswires) -- FMC Corporation ( FMC ) said Tuesday it is working with Optibrium to discover small molecules that can help with crop protection. Financial terms of the partnership were not disclosed. The agreement is part of FMC's strategic plan to accelerate the discovery and commercialization of the agriculture science company's pipeline. FMC will use...
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
May 14, 2024
May 14 (Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' ( DVAX ) hepatitis B vaccine in patients undergoing hemodialysis, the company said on Tuesday. ...
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
May 14, 2024
08:30 AM EDT, 05/14/2024 (MT Newswires) -- Profound Medical ( PROF ) said Tuesday that it received US Food and Drug Administration clearance for its TULSA-AI Contouring Assistant for use with its TULSA-PRO system to treat prostate disease. The medical device company said that TULSA uses pixel-by-pixel precision and sound technology to kill diseased prostate tissue without damaging urinary or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved